Dna X (SONM) Change in Accured Expenses (2018 - 2025)
Dna X's Change in Accured Expenses history spans 8 years, with the latest figure at -$1.9 million for Q4 2025.
- Quarterly results put Change in Accured Expenses at -$1.9 million for Q4 2025, up 31.66% from a year ago — trailing twelve months through Dec 2025 was -$2.0 million (down 124.47% YoY), and the annual figure for FY2025 was -$2.0 million, down 124.47%.
- Change in Accured Expenses for Q4 2025 was -$1.9 million at Dna X, down from $1.4 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $9.8 million in Q3 2024 to a low of -$2.9 million in Q1 2021.
- The 5-year median for Change in Accured Expenses is $198000.0 (2022), against an average of $347600.0.
- Peak annual rise in Change in Accured Expenses hit 1886.42% in 2023, while the deepest fall reached 778.1% in 2023.
- Year by year, Change in Accured Expenses stood at -$331000.0 in 2021, then surged by 124.47% to $81000.0 in 2022, then surged by 1886.42% to $1.6 million in 2023, then crashed by 275.7% to -$2.8 million in 2024, then surged by 31.66% to -$1.9 million in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$1.9 million, $1.4 million, and -$1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.